These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10449692

  • 1. Hormone replacement therapy and increased plasma concentration of C-reactive protein.
    Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE.
    Circulation; 1999 Aug 17; 100(7):713-6. PubMed ID: 10449692
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM.
    JAMA; 2002 Aug 28; 288(8):980-7. PubMed ID: 12190368
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
    Ryan AS, Nicklas BJ, Berman DM.
    Diabetes Care; 2002 Jan 28; 25(1):127-33. PubMed ID: 11772913
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences.
    Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV.
    Circulation; 2004 Jun 22; 109(24):3022-8. PubMed ID: 15184288
    [Abstract] [Full Text] [Related]

  • 11. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP, Madsen JS, Langdahl B, Bladbjerg EM, Tofteng CL, Abrahamsen B, Rejnmark L, Brixen K, Christensen K, Jespersen J, Kristensen SR.
    Thromb Haemost; 2007 Feb 22; 97(2):234-9. PubMed ID: 17264952
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use.
    Arsenault BJ, Earnest CP, Després JP, Blair SN, Church TS.
    Eur J Clin Nutr; 2009 Dec 22; 63(12):1419-24. PubMed ID: 19756031
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
    El-Swefy SE, Asker ME, Ali SI, Mohammed HE.
    Pharmacol Res; 2002 Mar 22; 45(3):167-73. PubMed ID: 11884211
    [Abstract] [Full Text] [Related]

  • 17. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Vitale C, Gebara O, Mercuro G, Wajngarten M, Silvestri A, Rossini P, Ramires JA, Fini M, Rosano GM.
    Maturitas; 2005 Apr 11; 50(4):239-46. PubMed ID: 15780522
    [Abstract] [Full Text] [Related]

  • 18. Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women.
    Koh KK, Shin MS, Sakuma I, Ahn JY, Jin DK, Kim HS, Kim DS, Han SH, Chung WJ, Shin EK.
    Arterioscler Thromb Vasc Biol; 2004 Aug 11; 24(8):1516-21. PubMed ID: 15166013
    [Abstract] [Full Text] [Related]

  • 19. Comparison of soft tissue body composition in postmenopausal women with or without hormone replacement therapy considering the influence of reproductive history and lifestyle.
    Dittmar M.
    Ann Hum Biol; 2001 Aug 11; 28(2):207-21. PubMed ID: 11293728
    [Abstract] [Full Text] [Related]

  • 20. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
    Albert MA, Glynn RJ, Ridker PM.
    Circulation; 2003 Jul 15; 108(2):161-5. PubMed ID: 12835213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.